Syksyllä on aika keskustella allergian siedätyshoidon aloittamisesta

Intolerance treatment is a fatal treatment of IgE-mediated allergic rhinitis and allergic conjunctivitis (hereinafter referred to as allergic rhinitis), allergic asthma, and wasp and bee stings allergy (hereinafter referred to as ‘stigma allergy’). The subject of treatment is the adverse symptoms of allergic rhinitis and asthma. In injection, the subject of the treatment is a severe general reaction caused by the injection site.

Intolerance treatment is effective and safe in allergic rhinitis and allergic eye symptoms, allergic asthma and allergy. The minimum age for desensitization is 5 years.

Tolerance therapy is given as sublingual tablets, sublingual injections or subcutaneous injections.

Timothy and room dust mite tablet and birch solution are used for sublingual delivery. Allergens for injections include birch, timothy, dust mite, Cladosporium, cat, dog and horse.

Talk to your patients in the autumn about the symptoms of the previous spring and allergy and tell you about the possibility of treatment. The patient does not remember to mention the cumbersome allergy symptoms in the early summer when coming to the reception, for example, due to the exacerbation of asthma or other acute symptoms. It only comes to mind next spring, when allergy symptoms start again.

If you end up with a patient with a tolerance treatment option, you will go to a special medical treatment for a treatment regimen. Some health centers have decided to initiate language-based care in primary health care. Before beginning treatment, ensure that the patient has an IgE-mediated allergy. symptom, and has no contraindications to starting treatment.

Tolerance treatment for eg birch and hay is started in the autumn. Treatment is initiated by a physician experienced in the study and treatment of allergic diseases. Care guidance is provided by the nurse.

The start-up phase of injection therapy is mainly carried out in special medical care, taking into account local conditions. The maintenance phase of the injection treatment is carried out under a regional agreement, either in primary health care or in specialized medical care.

For sublingual therapy, the first dose is given to the healthcare unit starting the treatment. In the future, the patient will take a sublingual tablet at home once a day for 3 years. The sublingual solution starts in early spring, continued daily in the early summer, ie about 5 months in three consecutive years.

Thus, the duration of the treatment is three years, usually five years for the injection.

During treatment, the patient should be monitored at least once a year and at the end of treatment either by a doctor or a caregiver at the place of treatment.

In animal allergy to inject delivery therapy, you can start at any time of the year, but start-up treatment for pollen allergy begins in the autumn after the end of the pollen season. Remember to always send a patient who has received a severe reaction to the injection into a special medical treatment for a dementia treatment.

So now is the time to discuss with the patient about the treatment of discomfort!

Erkka Valovirta, Specialist Doctor and Erja Tommila, Esh, Project Manager, Filha, National Allergy Program 2008–2018

https://www.filha.fi/fi/hankkeet/kansallinen-allergiaohjelma